Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266

Watchlist Manager
Suzhou Zelgen Biopharmaceuticals Co Ltd Logo
Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
Watchlist
Price: 64.04 CNY -4.28% Market Closed
Market Cap: 17B CNY
Have any thoughts about
Suzhou Zelgen Biopharmaceuticals Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Suzhou Zelgen Biopharmaceuticals Co Ltd

Wall Street analysts forecast Suzhou Zelgen Biopharmaceuticals Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Suzhou Zelgen Biopharmaceuticals Co Ltd is 59.16 CNY with a low forecast of 58.58 CNY and a high forecast of 60.9 CNY.

Lowest
Price Target
58.58 CNY
9% Downside
Average
Price Target
59.16 CNY
8% Downside
Highest
Price Target
60.9 CNY
5% Downside
Suzhou Zelgen Biopharmaceuticals Co Ltd Competitors:
Price Targets
ZYME
Zymeworks Inc
24% Upside
PSTX
Poseida Therapeutics Inc
423% Upside
SANA
Sana Biotechnology Inc
320% Upside
ARX
Aroa Biosurgery Ltd
45% Upside
ARWR
Arrowhead Pharmaceuticals Inc
160% Upside
006280
Green Cross Corp
43% Upside
ACLX
Arcellx Inc
26% Upside
086890
Isu Abxis Co Ltd
97% Upside

Revenue
Forecast

Revenue Estimate
Suzhou Zelgen Biopharmaceuticals Co Ltd

The compound annual growth rate of Suzhou Zelgen Biopharmaceuticals Co Ltd's revenue for the next 3 years is 71%.

N/A
Past Growth
71%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Suzhou Zelgen Biopharmaceuticals Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

Net Income
Forecast

Net Income Estimate
Suzhou Zelgen Biopharmaceuticals Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Suzhou Zelgen Biopharmaceuticals Co Ltd's stock price target?
Price Target
59.16 CNY

According to Wall Street analysts, the average 1-year price target for Suzhou Zelgen Biopharmaceuticals Co Ltd is 59.16 CNY with a low forecast of 58.58 CNY and a high forecast of 60.9 CNY.

What is Suzhou Zelgen Biopharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
71%

The compound annual growth rate of Suzhou Zelgen Biopharmaceuticals Co Ltd's revenue for the next 3 years is 71%.

Back to Top